Drug Development for Cancer and Diabetes: A Path to 2025

1st Edition

K. Saravanan, Chukwuebuka Egbuna, Horne Iona Averal, S. Kannan, S. Elavarasi, Bir Bahadur

Apple Academic Press
March 15, 2020 Forthcoming
Reference - 355 Pages - 13 Color & 31 B/W Illustrations
ISBN 9781771888608 - CAT# K441626

For Instructors Request Inspection Copy

was $179.95

USD$143.96

SAVE ~$35.99

Availabe for Pre-Order. This item will ship after March 15, 2020
Add to Wish List
FREE Standard Shipping!

Summary

Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases. It is structured in two parts. Part I consists of chapters that explores cancer cell cycle checkpoints, cancer biomarkers, essential drug properties, stages in anti-cancer drug development, and various bioactives that are effective against cancer. Part II presents a complete coverage of important advances and research discoveries in antidiabetic drugs. It details the potentials of medicinal plants and phytocompounds as sources for antidiabetic drugs and highlights the ethnobotanical basis of the compounds.

With chapters written by professionals in the field of phytochemistry and pharmacology from key institutions around the world, this volume provides a wide coverage and will be useful especially for scientists in pharmaceutical field.

Instructors

We provide complimentary e-inspection copies of primary textbooks to instructors considering our books for course adoption.

Request an
e-inspection copy

Share this Title